Your browser doesn't support javascript.
loading
Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.
Cavallo, Nicola Davide; Maietta, Paola; Perrotta, Silverio; Moretta, Pasquale; Carotenuto, Marco; Esposito, Maria; Santangelo, Gabriella; Santoro, Claudia.
Afiliação
  • Cavallo ND; Department of Psychology, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
  • Maietta P; Department of Psychology, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
  • Perrotta S; Child and Adolescent Neuropsychiatry Clinic, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Moretta P; Referral Centre of Neurofibromatosis, Department of Woman and Child, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Carotenuto M; Istituti Clinici Scientifici Maugeri IRCCS, Neuromotor Rehabilitation Unit of Telese Terme Institute, 82037 Benevento, Italy.
  • Esposito M; Child and Adolescent Neuropsychiatry Clinic, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Santangelo G; Child and Adolescent Neuropsychiatry Clinic, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Santoro C; Department of Psychology, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
Children (Basel) ; 11(8)2024 Aug 22.
Article em En | MEDLINE | ID: mdl-39201967
ABSTRACT

BACKGROUND:

Neurofibromatosis type 1 (NF1) is a genetic disorder that affects multiple systems in the body, often leading to physical disfigurements and a wide range of clinical symptoms. This study aims to investigate the relationship between NF1 severity and visibility and the quality of life (QoL) in children.

METHODS:

The Pediatric Quality of Life Inventory (PedsQL) and a modified version of the Ablon scale were used to assess QoL and NF1 severity and visibility, respectively. Self-reported and parent-reported QoL scores were compared, and the associations between NF1 severity/visibility and QoL were explored.

RESULTS:

Thirty-eight pediatric NF1 patients and their parents were enrolled. QoL scores did not differ significantly between patient self-reports and parent reports. However, correlational analyses revealed that higher NF1 severity was associated with lower physical QoL in patients, and greater NF1 visibility was linked to lower physical and social QoL. For parents, higher NF1 severity correlated with lower school functioning, whereas NF1 visibility did not show a significant correlation with QoL.

CONCLUSION:

The severity and visibility of NF1 have distinct impacts on various aspects of QoL in children, highlighting the need for tailored interventions that address both physical and psychological challenges. These findings underscore the importance of comprehensive care approaches in managing NF1 in pediatric populations.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Children (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Children (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália País de publicação: Suíça